
Can radiomics signatures predict tumor reponse of patients treated with chemotherapy and targeted therapy?
The authors of this retrospective study had the goal of evaluating the effectiveness of radiomics signatures in order to predict the tumor response of non-small cell lung cancer (NSCLC) patients who were treated with first-line chemotherapy, targeted therapy, or a combination of the two. The authors determined that radiomics signatures based on pre-treatment CT scans can accurately predict tumor response